Price Alert

Dr. Reddy's Laboratories ... (RDY)

NYSE: RDY · Real-Time Price · USD

14.22

0.11 (0.78%)

At close: Aug 15, 2025, 3:59 PM

14.22

-0.04%

After-hours: Aug 15, 2025, 05:16 PM EDT

Dr. Reddy's Laboratories Balance Sheet Statement

Financials in INR. Fiscal year is April - March.

Fiscal Year	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020
Cash & Equivalents	9B	14.65B	12.29B	11.33B	4.91B	7.11B	7.34B	13.39B	6.02B	5.78B	6.26B	9.1B	6.02B	14.85B	21.98B	9.98B	8.17B	14.83B	4.32B	3.89B	4.4B
Short-Term Investments	57.68B	43.25B	46.89B	51.74B	89.71B	74.36B	65.02B	54.39B	53.03B	60.97B	42.24B	18.48B	28.32B	29.51B	13.22B	14.6B	20.33B	19.74B	11.53B	21.15B	23.29B
Long-Term Investments	11.42B	15.2B	9.02B	5.98B	5.21B	5.25B	8.33B	5.92B	4.9B	6.09B	6.28B	6.11B	5.21B	7.99B	6.49B	7.49B	9.5B	8.33B	8.63B	3.99B	3.39B
Other Long-Term Assets	3.67B	2.79B	2.92B	3.79B	19.18B	5.35B	1.13B	812M	-14.45B	12.71B	-12.59B	1.8B	1.88B	948M	999M	882M	968M	952M	1.13B	1.14B	2.55B
Receivables	115.44B	109.79B	111.49B	102.84B	81.09B	80.3B	96.08B	89.69B	77.09B	72.48B	75.05B	76.99B	73.21B	66.76B	62.45B	68.61B	61.02B	49.64B	53.16B	50.08B	46.57B
Inventory	75.6B	71.08B	71.63B	72.04B	68.57B	63.55B	60.8B	56.59B	52.4B	48.67B	49.33B	49.04B	51.81B	50.88B	49.67B	49.7B	50.77B	45.41B	44.31B	41.13B	39.15B
Other Current Assets	4.66B	4.56B	5.41B	4.43B	24.91B	20.78B	24.73B	20.7B	20.51B	19.85B	21.61B	22B	20.06B	18.7B	19.51B	20.38B	18.48B	17.48B	20.09B	18.75B	19.53B
Total Current Assets	269.9B	250.11B	253.02B	248.13B	269.19B	248.05B	238.48B	217.69B	113.56B	204.25B	49.33B	175.61B	179.71B	181.11B	166.83B	163.27B	158.78B	148.25B	133.42B	135.01B	132.94B
Property-Plant & Equipment	102.78B	97.76B	93.05B	86.69B	80.34B	76.89B	72.8B	70.48B	67.21B	56.54B	65B	63.82B	63.83B	62.17B	62.97B	60.23B	58.64B	57.11B	56.26B	55.03B	54.18B
Goodwill & Intangibles	107.57B	108.61B	104.78B	103.89B	41.37B	41.2B	41.19B	41.28B	42.31B	36.2B	35.4B	36.08B	36.21B	31.66B	36.58B	37.21B	39.75B	40.22B	41.06B	45.55B	45.99B
Total Long-Term Assets	249.64B	242.88B	228.04B	217.83B	146.11B	139.47B	134.37B	129.33B	109.51B	118.6B	100.4B	115.37B	116.27B	115.55B	115.67B	115.23B	119.44B	117.24B	118.93B	118.37B	118.31B
Total Assets	519.54B	492.99B	481.06B	465.95B	415.3B	387.52B	372.84B	347.02B	335.04B	322.85B	309.3B	290.97B	295.98B	296.65B	282.5B	278.5B	278.21B	265.49B	252.35B	253.38B	251.24B
Account Payables	37.46B	20.05B	36.02B	35.78B	34.11B	21.55B	31.11B	30.48B	27.68B	17.86B	26.02B	22.78B	25.05B	15.97B	24.49B	25.55B	28.61B	12.7B	23.07B	22.83B	19.04B
Deferred Revenue	1.83B	1.98B	2B	1.53B	10.33B	1.44B	2.27B	3B	47.77B	1.98B	n/a	n/a	n/a	2.58B	5.6B	5.05B	4.84B	2.03B	5.33B	5.04B	4.76B
Short-Term Debt	42.18B	38.05B	42.4B	40.02B	23.16B	12.72B	12.34B	5.85B	6.47B	11.19B	15.27B	14.57B	21.7B	27.08B	21.33B	23.38B	26.3B	23.14B	13.11B	19.95B	24.05B
Other Current Liabilities	14.56B	13.52B	12.24B	9.77B	36.79B	19.97B	15.04B	15.34B	45.49B	16.95B	-16.21B	41.76B	42.98B	17.69B	31.43B	31B	30.87B	12.96B	31.53B	29.93B	31.29B
Total Current Liabilities	142.59B	130.39B	131.95B	129.3B	105.67B	96.04B	93.6B	84.18B	55.36B	85.72B	26.02B	80.03B	90.79B	97.84B	83.65B	85.9B	91.53B	81.47B	73.87B	78.57B	79.88B
Long-Term Debt	n/a	3.8B	3.8B	3.8B	3.8B	3.8B	3.8B	3.8B	3.8B	n/a	n/a	n/a	n/a	3.8B	3.8B	3.8B	3.8B	3.8B	3.8B	2.86B	3.8B
Other Long-Term Liabilities	2.49B	2.3B	5.16B	5.18B	8.71B	4.94B	5.24B	3.71B	4.02B	2.99B	24.57B	2.92B	2.89B	2.54B	2.74B	2.63B	2.35B	2.74B	2.51B	2.75B	2.77B
Total Long-Term Liabilities	23.19B	25.43B	27.54B	27.37B	15B	10.93B	11.39B	9.75B	9.01B	4.27B	26.02B	4.72B	4.79B	8.29B	8.83B	8.67B	8.57B	9.04B	9.08B	9.47B	9.61B
Total Liabilities	165.78B	155.82B	159.49B	156.67B	120.67B	106.97B	104.99B	93.94B	55.36B	89.99B	52.05B	84.75B	95.59B	106.13B	92.48B	94.57B	100.1B	90.51B	82.95B	88.04B	89.5B
Total Debt	48.64B	46.77B	51.09B	48.54B	30.68B	20.02B	19.85B	13.23B	12.52B	13.47B	17.66B	17.29B	24.67B	33.84B	28.16B	30.27B	33.37B	30.31B	20.44B	27.43B	31.58B
Common Stock	835M	834M	834M	834M	834M	834M	834M	834M	833M	833M	833M	832M	832M	832M	833M	832M	832M	832M	831M	831M	831M
Retained Earnings	329.97B	315.79B	299.35B	285.18B	279.83B	265.26B	252.08B	238.23B	230.02B	215.59B	206.71B	194.16B	187.81B	175.71B	174.91B	167.82B	161.76B	157.93B	152.19B	152.46B	150.04B
Comprehensive Income	3.98B	3.98B	4.48B	4.52B	4.11B	653M	762M	810M	864M	1.27B	553M	631M	833M	1.06B	982M	1.01B	1.3B	1.33B	1.53B	1.06B	3.14B
Shareholders Equity	350.06B	333.39B	317.72B	305.34B	294.63B	280.55B	267.85B	253.09B	245.26B	232.86B	220.27B	206.22B	200.39B	190.53B	190.02B	183.93B	178.11B	174.98B	169.4B	165.34B	161.75B
Total Investments	69.1B	58.46B	55.91B	57.72B	94.92B	79.62B	73.35B	60.31B	57.94B	67.06B	48.52B	24.59B	33.54B	37.5B	19.71B	22.09B	29.83B	28.08B	20.16B	25.15B	26.68B